K
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
Price:
3 210
KRW
0.78%
Market Closed
Market Cap:
₩161.1B
Balance Sheet
Balance Sheet Decomposition
Kukjeon Pharmaceutical Co Ltd
Kukjeon Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
Kukjeon Pharmaceutical Co Ltd
Kukjeon Pharmaceutical Co Ltd
Balance Sheet
Kukjeon Pharmaceutical Co Ltd
Kukjeon Pharmaceutical Co Ltd
Currency: KRW
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1 321
|
284
|
9 779
|
19 099
|
21 546
|
10 992
|
46 824
|
|
| Cash |
0
|
0
|
0
|
4
|
7
|
15
|
14
|
|
| Cash Equivalents |
1 321
|
284
|
9 779
|
19 095
|
21 539
|
10 978
|
46 810
|
|
| Short-Term Investments |
0
|
1 000
|
180
|
20 160
|
73 425
|
53 840
|
0
|
|
| Total Receivables |
3
|
68
|
16 299
|
20 409
|
23 919
|
29 101
|
29 475
|
|
| Accounts Receivables |
3
|
68
|
16 289
|
20 149
|
22 500
|
26 946
|
28 782
|
|
| Other Receivables |
0
|
0
|
10
|
261
|
1 420
|
2 155
|
693
|
|
| Inventory |
0
|
0
|
12 043
|
16 207
|
20 209
|
27 563
|
26 798
|
|
| Other Current Assets |
0
|
0
|
703
|
1 040
|
3 794
|
2 495
|
2 092
|
|
| Total Current Assets |
1 324
|
1 352
|
39 004
|
76 915
|
142 893
|
123 992
|
105 189
|
|
| PP&E Net |
0
|
0
|
14 473
|
24 026
|
46 118
|
86 060
|
87 360
|
|
| PP&E Gross |
0
|
0
|
0
|
24 026
|
46 118
|
86 060
|
87 360
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
8 071
|
8 914
|
11 750
|
17 072
|
|
| Intangible Assets |
0
|
0
|
409
|
422
|
904
|
971
|
4 408
|
|
| Goodwill |
0
|
0
|
0
|
0
|
420
|
420
|
420
|
|
| Note Receivable |
0
|
0
|
866
|
821
|
210
|
240
|
220
|
|
| Long-Term Investments |
9 000
|
9 000
|
1 943
|
3 753
|
3 429
|
10 618
|
11 511
|
|
| Other Long-Term Assets |
0
|
0
|
1 108
|
1 053
|
2 123
|
2 801
|
3 164
|
|
| Other Assets |
0
|
0
|
0
|
0
|
420
|
420
|
420
|
|
| Total Assets |
10 324
N/A
|
10 352
+0%
|
57 802
+458%
|
106 989
+85%
|
196 097
+83%
|
225 102
+15%
|
212 273
-6%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
7 749
|
10 989
|
9 474
|
11 693
|
17 833
|
|
| Accrued Liabilities |
0
|
0
|
0
|
83
|
180
|
293
|
363
|
|
| Short-Term Debt |
0
|
0
|
11 458
|
5 133
|
7 883
|
15 224
|
8 560
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
726
|
1 582
|
26 162
|
37 039
|
32 094
|
|
| Other Current Liabilities |
0
|
0
|
1 848
|
4 064
|
26 992
|
35 574
|
29 726
|
|
| Total Current Liabilities |
0
|
0
|
21 782
|
21 852
|
70 691
|
99 823
|
88 576
|
|
| Long-Term Debt |
636
|
700
|
3 000
|
1 137
|
25 293
|
26 517
|
24 657
|
|
| Deferred Income Tax |
74
|
72
|
0
|
0
|
1 365
|
10
|
10
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
726
|
1 035
|
79
|
|
| Other Liabilities |
0
|
0
|
791
|
850
|
6 425
|
1 296
|
1 529
|
|
| Total Liabilities |
710
N/A
|
772
+9%
|
25 572
+3 212%
|
23 838
-7%
|
104 500
+338%
|
128 681
+23%
|
114 853
-11%
|
|
| Equity | ||||||||
| Common Stock |
501
|
501
|
3 854
|
4 907
|
4 907
|
4 907
|
4 907
|
|
| Retained Earnings |
27
|
61
|
11 810
|
15 848
|
24 305
|
29 129
|
30 375
|
|
| Additional Paid In Capital |
9 140
|
9 140
|
16 566
|
62 397
|
62 386
|
62 386
|
62 139
|
|
| Treasury Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Equity |
9 614
N/A
|
9 580
0%
|
32 230
+236%
|
83 150
+158%
|
91 597
+10%
|
96 422
+5%
|
97 420
+1%
|
|
| Total Liabilities & Equity |
10 324
N/A
|
10 352
+0%
|
57 802
+458%
|
106 989
+85%
|
196 097
+83%
|
225 102
+15%
|
212 273
-6%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
5
|
5
|
42
|
49
|
49
|
49
|
49
|
|
Switch to:
Switch to:
See Also
Discover More
